Cosette Pharmaceuticals, Inc. (Cosette), a U.S.-based, fully integrated pharmaceutical company, confirms that on 9 December ...
- Three Phase 2 data readouts from lead programs, EVO756 and EVO301, expected in 2026 across atopic dermatitis (AD) and ...
Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation ...
Avenzo Therapeutics, Inc. (“Avenzo”), a clinical-stage biotechnology company developing next-generation oncology therapies, ...
Antin Infrastructure Partners (Paris:ANTIN) has agreed to acquire NorthC Datacenters, a leading enterprise colocation data ...
Leadership Changes to Take Effect Following Conclusion of Ordinary General Meeting of Shareholders in March 2026Announcement ...
Funding will further scale the company’s multimodal ML platform for patient selectionSAN FRANCISCO--(BUSINESS ...
Concise regulatory statusPivotal trialOveporextonTakedaNarcolepsy (orexin‑2 agonist)US, EU, JPPhase III completed; filings ...
Accenture (NYSE: ACN) has invested in Ryght AI, a platform provider that modernizes how clinical research is designed and ...
TURKU, FI / ACCESS Newswire / December 11, 2025 / Faron Pharmaceuticals Ltd. (AIM:FARN, First North:FARON, "Faron" or the ...
OverviewThe global urology surgical instruments market is projected to witness steady growth at an approximate CAGR of 8% ...
OverviewThe global dental soft-tissue regeneration market is poised to grow steadily at a CAGR of nearly 7% during the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback